Cover image of Neurology® Podcast
(113)

Rank #62 in Medicine category

Health & Fitness
Medicine
Science

Neurology® Podcast

Updated about 1 month ago

Rank #62 in Medicine category

Health & Fitness
Medicine
Science
Read more

The Neurology podcast is introduced by Editor-in-Chief Robert A. Gross, MD, PhD, who discusses several highlighted articles in the current issue of Neurology®. The podcast regularly features content from Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation. Opening segments include interviews with authors who summarize a current article and discuss the main findings and clinical implications for neurologists. It concludes with the Lesson of the Week, a short segment on a topic such as a laboratory technique, statistical methods, or historical neurology. Regular features also include Delayed Recall, ePearls, and What’s Trending. Podcast listeners can earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions related to Neurology content in the online Podcast Quiz. (Delayed recall, Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation contents are excluded from the CME program). The exams are posted weekly on Wednesday.

Read more

The Neurology podcast is introduced by Editor-in-Chief Robert A. Gross, MD, PhD, who discusses several highlighted articles in the current issue of Neurology®. The podcast regularly features content from Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation. Opening segments include interviews with authors who summarize a current article and discuss the main findings and clinical implications for neurologists. It concludes with the Lesson of the Week, a short segment on a topic such as a laboratory technique, statistical methods, or historical neurology. Regular features also include Delayed Recall, ePearls, and What’s Trending. Podcast listeners can earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions related to Neurology content in the online Podcast Quiz. (Delayed recall, Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation contents are excluded from the CME program). The exams are posted weekly on Wednesday.

iTunes Ratings

113 Ratings
Average Ratings
86
16
4
2
5

Informative and relevant!

By Superstumbler - Mar 01 2020
Read more
Content is definitely a 5 but the audio quality could be better.

Best brain pod!

By nordiknut - Feb 25 2020
Read more
Highest praise!!! A MUST for Neurology residents!

iTunes Ratings

113 Ratings
Average Ratings
86
16
4
2
5

Informative and relevant!

By Superstumbler - Mar 01 2020
Read more
Content is definitely a 5 but the audio quality could be better.

Best brain pod!

By nordiknut - Feb 25 2020
Read more
Highest praise!!! A MUST for Neurology residents!
Cover image of Neurology® Podcast

Neurology® Podcast

Latest release on Jul 06, 2020

Read more

The Neurology podcast is introduced by Editor-in-Chief Robert A. Gross, MD, PhD, who discusses several highlighted articles in the current issue of Neurology®. The podcast regularly features content from Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation. Opening segments include interviews with authors who summarize a current article and discuss the main findings and clinical implications for neurologists. It concludes with the Lesson of the Week, a short segment on a topic such as a laboratory technique, statistical methods, or historical neurology. Regular features also include Delayed Recall, ePearls, and What’s Trending. Podcast listeners can earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions related to Neurology content in the online Podcast Quiz. (Delayed recall, Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation contents are excluded from the CME program). The exams are posted weekly on Wednesday.

Rank #1: Delayed Recall - Neuro-oncology Lessons of the Week (July 2017)

Podcast cover
Read more
In this month's Delayed Recall episode, we are featuring four interviews by Dr. Kait Nevel on the topic of neuro-oncology. In the first interview, Dr. Nevel speaks with Dr. Jennie Taylor about neuro-oncology and seizures. In the second, she discusses intracranial pressure with Dr. Mariza Daras. These interviews originally appeared in the March 7 and March 14 episodes, respectively. Next, Dr. Nevel and Dr. Lisa DeAngelis talk about metastatic diseases in neurology, in a segment that appeared in the March 21 episode. Last, Dr. Nevel discusses gliomas with Dr. David Schiff in an interview from March 28.

Jul 01 2017

46mins

Play

Rank #2: Delayed Recall - Concussion and Chronic Traumatic Encephalopathy (September 2017)

Podcast cover
Read more
The first interview in this month’s Delayed Recall episode is from March 17, 2015; in this interview, Dr. Howard Goodkin and Dr. Robert Stern discuss the effect that age of first exposure to football has on later-life cognitive impairment in former NFL players. The second interview, from August 29, 2017, is a discussion between Dr. Jason Crowell and Dr. Jesse Mez about a July 2017 JAMA paper on occurrence of CTE in American football players. In the third interview, Dr. Christopher Giza speaks with Dr. John Hart about Dr. Hart’s paper regarding depressive symptoms and white matter dysfunction in retired NFL players with concussion history. This interview originally appeared in the July 1, 2013 episode. The fourth and final interview is a discussion between Dr. Ted Burns and former NFL player Ben Utecht, regarding Mr. Utecht’s Sept 23, 2014 editorial, “Concussed.”

Sep 01 2017

48mins

Play

Rank #3: Delayed Recall - Anoxic brain injury (October 2016)

Podcast cover
Read more
Interviews on evaluation of the anoxic brain injury patient.

Oct 03 2016

37mins

Play

Rank #4: April 29 2014 Issue

Podcast cover
Read more
1) AAN paper on efficacy and safety of the therapeutic use of medical marijuana (Cannabis) in selected neurologic disorders and 2) Topic of the month: Therapeutics in epilepsy. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Joanna Suski interviews Dr. Barbara Koppel about the AAN paper on efficacy and safety of the therapeutic use of medical marijuana (Cannabis) in selected neurologic disorders. Dr. Adam Numis is reading our e-Pearl of the week about myoclonic astatic epilepsy. In the next part of the podcast Dr. Lara Marcuse interviews Dr. Greg Bergey about epilepsy therapeutics: Beyond medications for the refractory patient. The participants had nothing to disclose except Drs. Koppel, Numis and Bergey.Dr. Koppel serves as an editorial board member of Clinical Neurology.Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Bergey was an expert witness in medicolegal activity over the past two years and receives research support from the NIH.

Apr 28 2014

29mins

Play

Rank #5: Delayed Recall - March 2016

Podcast cover
Read more
Tele-neurology and tele-stroke - from September 2015 LOTWs

Feb 29 2016

52mins

Play

Rank #6: Responsible Opioid Prescribing—Special Podcast #3

Podcast cover
Read more
We are producing and releasing 4 special podcast interviews this month dedicated to responsible opioid prescribing. We are doing this largely as a response to the ongoing opioid epidemic in the U.S. and around the world. In Special Podcasts 3 and 4, Dr. Andy Southerland interviews Dr. Gary Franklin from the University of Washington. Many state boards in the U.S. are now requiring a few hours of CME for responsible opioid prescribing practices, and these podcasts may be eligible for a total 2 hours of Category 1 CME, however please check with your individual U.S. state Board of Medicine mandates. Regardless of CME, we felt these topics deserved covering and we hope you check out all four episodes and find them helpful and informative.

May 16 2017

23mins

Play

Rank #7: Stroke risk, prevention and treatment (Delayed Recall - November 2018)

Podcast cover
Read more
This month’s Delayed Recall highlights episodes on stroke risk, prevention and treatment. Dr. Jim Siegler and Dr. Christian Gerloff begin the show discussing the results of the WAKE-UP stroke trial. This episode first aired on October 2, 2018. The next segment, from September 11, 2018 focuses on acute ischemic stroke, where Dr. Dan Ackerman talks with Dr. Andrei Alexandrov about his paper on dual antiplatelet therapy pretreatment. This interview is followed by a segment that first appeared in the August 21, 2018 show on silent infarct and the risk of infarct recurrence in adults with sickle cell anemia with Dr. Justin Sattin and Dr. Lori Jordan. The episode concludes with another interview on acute ischemic stroke from August 14, 2018 investigating a POINT study on Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA with Dr. Will Rondeau interviewing Dr. Clay Johnston.

Nov 01 2018

51mins

Play

Rank #8: April 15 2014 Issue

Podcast cover
Read more
1) Skin nerve a-synuclein deposits being a biomarker for idiopathic Parkinson disease and 2) Topic of the month: Therapeutics in epilepsy. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jeff Ratliff interviews Dr. Vincenzo Donadio about his paper on skin nerve ?-synuclein deposits being a biomarker for idiopathic Parkinson disease. Dr. Adam Numis is reading our e-Pearl of the week about cognitive impairment in pediatric multiple sclerosis. In the next part of the podcast Dr. Lara Marcuse interviews Dr. Nathan Fountain about epilepsy therapeutics: Lacosamide. The participants had nothing to disclose except Drs. Fountain and Numis.Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Fountain serves as Vice-President of the National Association of Epilepsy Centers; performs EEG lab work and EEG interpretation in his clinical practice (10% effort); receives research support from UCB, SK Life Sciences, Sunovion, Medtronic, NeuroPace; and the NIH.

Apr 14 2014

21mins

Play

Rank #9: May 24 2016 Issue

Podcast cover
Read more
1) Natural history of cavernous malformation: Systematic review and meta-analysis of 25 studies2) e-Pearl topic: Neurologic manifestations of hereditary hemorrhagic telangiectasia3) Topic of the month: Neurology Today story about new Center for Disease Control guidelines on prescribing opioids (Part 1)This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Matthew Flaherty interviews Dr. Loch Macdonald about his paper on review and meta-analysis of 25 studies about the natural history of cavernous malformation. Dr. Adam Numis is reading our e-Pearl of the week about neurologic manifestations of hereditary hemorrhagic telangiectasia. Dr. Ted Burns interviews Dr. Gary Franklin about a Neurology Today story on the topic of the new Center for Disease Control guidelines on prescribing opioids (Part 1).DISCLOSURES: Dr. Flaherty serves on the scientific advisory board for DSMB member, I-DEF Trial (NINDS sponsored ICH treatment trial); has a patent pending, non-invasive CNS monitor; owns company stock as co-founder of SENSE Diagnostics, LLC (our product is currently investigational and not on the market); serves on the speakers' bureau of CSL Behring and Janssen; receives research support from American Heart Association, Pfizer Inc, Bristol-Myers Squibb, NIH and as Principal Investigator of a phase II, NINDS funded trial testing recombinant activated factor VII for treatment of intracerebral hemorrhage where study drug is supplied by Novo Nordisk.Dr. Macdonald serves as an editorial board member of Stroke, Journal of Neurosurgery, Neurosurgery, Journal of cerebral blood flow and metabolism, Neurocritical care, World Neurosurgery, Surgical Neurology International, Translational stroke research and Cerebrovascular diseases; treats unruptured aneurysm patients (1% effort); holds stock options in Edge Therapeutics, Inc; has a patent for treatment of delayed cerebral ischemia and subdural hemorrhage, intracranial drug delivery systems; receives research support from Canadian Institutes of Health Research, Brain Aneurysm Foundation, Heart and Stroke Foundation of Canada and Physicians Services Incorporated Foundation.Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section.Dr. Ted Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with UCB, CSL Behring, Walgreens and Alexion Pharmaceuticals, Inc.Dr. Franklin serves as an editorial board member of Neuroepidemiology; serves on the Levels of Evidence Team for Neurology®; is a consultant for the California State Compensation Insurance Fund; receives research support from the Centers for Disease Control and Prevention.

May 23 2016

23mins

Play

Rank #10: Delayed Recall - Patient Perspectives, Part II (January 2018)

Podcast cover
Read more
Patient Perspectives, Part II (January 2018)This month’s Delayed Recall episode is the second part of our feature including interviews that focus on the patient perspective. The first part of this feature aired as the Delayed Recall episode for December 2017. We feature four interviews in this second installment; the first is Dr. Alberto Espay’s interview with Dr. Ted Burns in the Sept. 3, 2013 episode, in which they discuss Dr. Burns’ cancer diagnosis and his subsequent experience as a patient. In the second interview, with Dr. Lara Marcuse, Dr. Marcuse responds to Dr. Espay’s Sept. 2013 interview with Dr. Burns, and remarks briefly on her own time as a patient. This interview was part of the October 29, 2013 episode. The third interview features Dr. Espay and Dr. Burns once more; they discuss Dr. Burns’ cancer recurrence, as well as Dr. Burns’ view about the kind of care that he believes is important for healthcare providers to focus on. This interview first appeared in the August 1, 2017 episode. Last, we feature an interview from the June 3, 2008 episode, between Dr. Ted Burns and Dr. Bob Joynt, in which Dr. Joynt offers his advice regarding patient treatment.

Dec 31 2017

47mins

Play

Rank #11: Delayed Recall - Cognitive Impairment (March 2018)

Podcast cover
Read more
This month’s Delayed Recall episode includes three recent interviews on the topic of cognitive impairment. In the first interview, from the January 16, 2018 episode, Dr. Jeff Burns speaks with Dr. Ronald Petersen about the recent AAN practice guideline paper on mild cognitive impairment. Next, in and interview from the January 2, 2018 podcast, Dr. Ted Burns and Dr. Damian Garde discuss recent Alzheimer disease trials; and in the third and final interview, Dr. Matthew Elliot talks with Dr. Hugh Markus about his paper “Multimodal MRI markers and dementia risk in cerebral small vessel disease.” This interview first aired in the October 31, 2017 episode of the podcast.

Mar 06 2018

27mins

Play

Rank #12: Neurology Recall: Myelopathies

Podcast cover
Read more

In this replay of past episodes of Delayed Recall, we have the April 2015 interviews focusing on systemic causes of myelopathies and, then, interviews from 2018 on acquired myelopathies. 

May 02 2020

1hr 1min

Play

Rank #13: Practice Current: Managing Epilepsy during Pregnancy (April 2018)

Podcast cover
Read more
This special Delayed Recall episode is the third installment of our new Practice Current segment. In this episode, Dr. Luca Bartolini speaks with epilepsy experts Dr. Cynthia Harden and Dr. Torbjörn Tomson. They discuss the results of a recent Practice Current (a section of Neurology® Clinical Practice) survey regarding epilepsy treatment and management during pregnancy, and share their thoughts regarding best practices. This is the first appearance of this interview in the podcast.

Apr 02 2018

27mins

Play

Rank #14: July 19 2016 Issue

Podcast cover
Read more
1) Zika virus-associated Guillain-Barre Syndrome Variant in Haiti2 e-Pearl topic: Juvenile Huntington Disease3) Topic of the month: Clinical Trials Plenary Session at the AAN meeting about 5-HT6 antagonist as adjunctive therapy to cholinesterase inhibitors in patients with mild-to-moderate Alzheimer diseaseThis podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Stephen Donahue interviews Dr. Aaron Berkowitz about his paper on Zika virus-associated Guillain-Barre syndrome variant in Haiti. Dr. Ilena George is reading our e-Pearl of the week about juvenile Huntington disease. Dr. Alberto Espay interviews Dr. Alireza Atri about his Clinical Trials Plenary Session at the AAN meeting about 5-HT6 antagonist as adjunctive therapy to cholinesterase inhibitors in patients with mild-to-moderate Alzheimer disease.DISCLOSURES: Dr. Berkowitz receives royalties from the publication of the book: Clinical Pathophysiology Made Ridiculously Simple and the book: The Improvising Mind; received funding for travel from Stevens Institute of Technology; received speaker honorarium from Audio Digest; and received honorarium for recorded CME lecture.Dr. George serves on the editorial team for the Neurology® Resident and Fellow Section.Dr. Espay serves as Associate Editor for the Journal of Clinical Movement Disorders; serves as an editorial board member of Parkinsonism and Related Disorders and The European Neurological Journal; serves on the scientific advisory board for Solvay Pharmaceuticals, Inc. (now Abbvie), Chelsea Therapeutics International, Ltd., Teva Pharmaceutical Industries Ltd., Impax, Merz Pharmaceuticals, Inc., Pfizer Inc, Solstice Neurosciences, Eli Lilly and Company, ACADIA Pharmaceuticals, Inc. and USWorldMeds; is a consultant for Chelsea Therapeutics International, Ltd., Solvay Pharmaceuticals, Inc. (now Abbvie), ACADIA Pharmaceuticals, Inc., Cynapsus and Lundbeck, Inc; receives royalties for publications of books from Lippincott, Williams & Wilkins and Cambridge University Press; serves on the speakers' bureau of UCB, Teva Pharmaceutical Industries Ltd., American Academy of Neurology and Movement Disorders Society; receives research support from the CleveMed/Great Lake Neurotechnilogies, Michael J. Fox Foundation and the NIH.

Jul 18 2016

27mins

Play

Rank #15: Delayed Recall - Autoimmune & Paraneoplastic Encephalitis (May 2015)

Podcast cover
Read more
Autoimmune & Paraneoplastic Encephalitis. Lesson of the Week interviews from February 2015.

May 01 2015

44mins

Play

Rank #16: Current treatment practice of Guillain-Barré syndrome

Podcast cover
Read more

In the first segment, Dr. Michelle Mauermann talks with Dr. Bart Jacobs about his paper on current treatment practice of Guillain-Barré syndrome. In the second part of the podcast, Dr. Matthew Harms focuses his discussion with Dr. Guy Rouleau on his Neurology: Genetics paper looking at how somatic expansion of the C9orf72 Hexanucleotide Repeat does not occur in ALS spinal cord tissues.

Jul 01 2019

16mins

Play

Rank #17: May 3 2016 Issue

Podcast cover
Read more
1) Neurology® Neuroimmunology & Neuroinflammation: VZV in biopsy-positive and -negative giant cell arteritis: analysis of 100+ temporal arteries2) What's Trending: Interview with Kimberley R. Barker about “altmetrics”3) Topic of the month: Neurology Today story about epidemiologists tracking possible links between Zika virus, microcephaly, and Guillain–Barre syndromeThis podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Dr. Don Gilden about his Neurology: Neuroimmunology & Neuroinflammation paper on varicella zoster virus in over 100 temporal arteries that showed clinical features of giant cell arteritis. Dr. Andy Southerland is interviewing Kimberley R. Barker for our “What's Trending” feature of the week about “altmetrics.” Dr. Ted Burns interviews Dr. James Sejvar about a Neurology Today story on the topic of epidemiologists tracking possible links between Zika virus, microcephaly, and Guillain–Barre syndrome.DISCLOSURES: Dr. Ted Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with UCB, CSL Behring, Walgreens and Alexion Pharmaceuticals, Inc.Dr. Gilden serves as Senior Associate Editor for Journal of NeuroVirology, serves as an editorial Board member of In Vivo, Journal of Virology, Scientific American Medicine, Virus Genes, Neurology®, and the Journal of the Nuerological Sciences; receives research support from the NIH.Dr. Southerland serves as Podcast Deputy Editor for Neurology; receives research support from the American Heart Association-American Stroke Association National Clinical Research Program, American Academy of Neurology, American Board of Psychiatry and Neurology, Health Resources Services Administration and the NIH; has a provisional patent application titled: “Method, system and computer readable medium ofr improving treatment times for rapid evaluation of acute stroke via mobile telemedicine;” and gave legal expert review.NO CME WILL BE OFFERED THIS WEEK.

May 02 2016

35mins

Play

Rank #18: February 14 2017

Podcast cover
Read more
1) Prognosis of carotid dissecting aneurysms: results from CADISS and a systematic review2) What's Trending: CRISPR gene editing in neuromuscular diseases3) Neurology Today® paper – spotlight on Dr. John NoseworthyThis podcast begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the February 14, 2017 issue of Neurology. In the first segment, Dr. Andy Southerland talks with Dr. Hugh Markus about his paper on the prognosis of carotid dissecting aneurysms. For our "What's Trending" feature of the week, Dr. Ted Burns interviews Dr. Eric Olson regarding CRISPR at the 2016 AANEM meeting. In the next part of the podcast, Dr. Ted Burns speaks with Mayo Clinic CEO Dr. John Noseworthy about his meeting with President Trump and his experience as Editor-in-Chief of Neurology. Disclosures can be found at Neurology.org.DISCLOSURES:Dr. Southerland serves as Podcast Deputy Editor for Neurology; receives research support from the American Heart Association-American Stroke Association National Clinical Research Program, American Academy of Neurology, American Board of Psychiatry and Neurology, Health Resources Services Administration and the NIH; has a provisional patent application titled: “Method, system and computer readable medium for improving treatment times for rapid evaluation of acute stroke via mobile telemedicine;” and gave legal expert review. Dr. Markus has served on the editorial boards of the International Journal of Stroke, Clinical Neurology and Neurosurgery, BMC Medicine, and Frontiers in Neurology; receives publishing royalties from Oxford University Press; has received reimbursement from Astra Zeneca for teaching a session to employees; and has received research support from NIHR, Stroke Association, EU, Wellcome Trust, The British Heart Foundation, and Alzheimer Research UK.Dr. Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with UCB, CSL Behring, Walgreens and Alexion Pharmaceuticals, Inc. Dr. Eric Olson holds patents describing DMD gene editing.Dr. Noseworthy receives publishing royalties for the following publications: Fifty Neurologic Cases, Oxford, 2004, Multiple Sclerosis 2, Blue Books; Butterworth, 2003, Neurologic Therapeutics, Edition 1, Martin Dunitz, 2003, Neurologic Therapeutices, Edtion 2, Informa, 2006, McAlpine's Multiple Sclerosis, 4th Edition, 2006.All other participants have no disclosures.

Feb 13 2017

33mins

Play

Rank #19: Epilepsy and EEG (Delayed Recall July 2019)

Podcast cover
Read more

This month's Delayed Recall highlights interviews on epilepsy and EEG. Dr. Derek Bauer talks with Dr. Paula Emanuela Voinescu about her paper on antiepileptic drug clearances during pregnancy and the relationship between drug serum concentration and seizure frequency from the Sept 25, 2018, podcast.  Next, Dr. Andy Schomer talks with Dr. Chloe Hill on the association between continuous EEG and favorable hospitalization outcomes for critically ill patients from the January 1, 2019, podcast.  For the next segment, we’re back with Derek Bauer, this time talking with Dr. Jacqueline French about the recent practice guideline on the treatment of new-onset epilepsy from the July 10, 2018 episode. And then again from the April 2, 2019, podcast, we hear Derek Bauer talk with Dr. Stephan Schuele about his paper on automated seizure detection accuracy for ambulatory EEG recordings.  Finally, we wrap up with Jeff Ratliff talking to Dr. Anup Patel about the 2017 epilepsy quality measurement set update, which originally aired on the October 30, 2018, podcast.  

Jul 01 2019

43mins

Play

Rank #20: Treatment of Adult ADHD; Surrogates' Decisions after Acute Brain Injury

Podcast cover
Read more

In the first segment, Dr. Teshamae Monteith talks with Dr. Scott Hirsch about treatment of adult ADHD. In the second segment, Dr. David Lapides talks with Dr. David Hwang about his Neurology paper on factors impacting surrogate decision makers for acute brain injury patients. 

Disclosures can be found at Neurology.org.

CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.

May 11 2020

22mins

Play

Allele-Selective Therapy in HD; Telephone based CBT In Parkinson’s

Podcast cover
Read more

In the first segment, Dr. Jason Crowell talks with Dr. Daniel Claassen about his Neurology: Genetics paper on genotyping single nucleotide polymorphisms for allele-selective therapy in Huntington disease. In the second part of the podcast, Dr. Jeffrey Ratliff focuses his discussion with Dr. Roseanne Dobkin on telephone-based CBT for depression in patients with Parkinson disease.

Disclosures can be found at Neurology.org.

No CME this week: Interviews based on articles from Neurology: Clinical Practice®, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation are excluded from the CME program.

Jul 06 2020

26mins

Play

Diagnosis and Management of Post-concussive Headache (Practice Current July 2020)

Podcast cover
Read more

Dr. Luca Bartolini leads a roundtable discussion on diagnosis and management of post-concussive headache with experts Dr. Teshamae Monteith and Dr. Marc DiSabella based on a Practice Current survey run between March and November 2019. 

Jul 01 2020

24mins

Play

Managing Status Epilepticus, part 2

Podcast cover
Read more

In the 2nd part of this 2-part series, Dr. Halley Alexander interviews Dr. Michael Sperling about management of status epilepticus. 

Jun 29 2020

19mins

Play

Managing Status Epilepticus, part 1

Podcast cover
Read more

In the 1st part of this 2-part series, Dr. Halley Alexander interviews Dr. Michael Sperling about management of status epilepticus. 

Jun 22 2020

25mins

Play

Mononeuropathies (Neurology Recall--June 19, 2020)

Podcast cover
Read more

In this replay of previous episodes, Dr. Ted Burns talks with John D. Stewart on the common mononeuropathies: median, ulnar, radial, and paroneal. 

Jun 19 2020

43mins

Play

Diagnosing Neurosarcoidosis; Use of Progenitor Cells in Parkinson Disease

Podcast cover
Read more

In the first segment, Dr. David Lapides talks with Dr. Tarunya Arun about her paper discussing diagnosis of neurosarcoidosis. In the second part of the podcast, Dr. Jeffrey Ratliff talks with Dr. Jeffrey Schweitzer about his NEJM paper discussing progenitor cells for Parkinson disease. Read the NEJM article here: https://bit.ly/2XjHvuc.

Disclosures can be found at Neurology.org.

CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.

Jun 15 2020

22mins

Play

Managing Migraine, pt. 2; NFL as a biomarker after mild TBI

Podcast cover
Read more

In the first segment, you'll hear the second part of an interview on migraine between Dr. Jason Crowell and Dr. David Watson, focusing on special patient populations in management of migraine. In the second segment, Dr. David Lapides talks with Dr. Kimbra Kenney and Dr. Jessica Gill about their paper on NFL as a biomarker following traumatic brain injury. 

Disclosures can be found at Neurology.org.

CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.

Jun 08 2020

21mins

Play

Managing Migraine; How to improve using Quality Outcomes Measurement Sets

Podcast cover
Read more

In the first segment, Dr. Jason Crowell talks with Dr. David Watson about managing migraine in the first part of a two-part series. In the second segment, Dr. Jeff Ratliff talks with Dr. Jason Jonathan Sico about his Neurology paper on improving quality outcomes measurement sets. Part of the information in the discussion with Dr. Watson can be found in this paper in Current Pain and Headache Reports: https://link.springer.com/article/10.1007/s11916-019-0749-1

Disclosures can be found at Neurology.org.

CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.

Jun 01 2020

19mins

Play

Neuromyelitis Optica Treatment (Neurology Recall June 2020)

Podcast cover
Read more

In this replay of previous episodes, we features discussions on the treatment of neuromyelitis optica. We begin with Dr. Ted Burns' interview of Dr. Stacey Clardy from Dec. 2019 on treatment and prevention of disease activity. From October 2019, Dr. Stacey Clardy talks with Dr. Sean Pittock on eculizumab in aquaporin-4–positive neuromyelitis optica spectrum disorder. The 3rd segment is from Nov. 2019 and features Dr. Clardy's talk with Dr. Silvia Tenembaum about prognostic indicators of improvement with therapeutic plasma exchange in pediatric demyelination. Next, there's Stacey Clardy's talk with Dr. Richard Burt on autologous, nonmyeloablative hematopoietic stem-cell transplantation for neuromyelitis optica. Finally, Dr. Jeff Ratliff talks with Dr. Maureen Mealy, from May 2020, about scrambler therapy for NMO-related pain. 

May 29 2020

1hr 6mins

Play

Insomnia Treatment in the Elderly; Living with Huntington's Part 2

Podcast cover
Read more

In the first segment, Dr. Jeffrey Ratliff talks with Dr. Yves Dauvilliers about their paper on insomnia treatment in the elderly. In the second part of the podcast, Dr. Jason Crowell continues his talk with Dr. Nancy Wexler about living with Huntington's disease.

Disclosures can be found at Neurology.org.

CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.

May 25 2020

18mins

Play

Living with Huntington's Disease (part 1); Latest on PFO and stroke

Podcast cover
Read more

In the first segment, you'll hear the first part of an interview between Dr. Jason Crowell and Dr. Nancy Wexler on living with Huntington's disease. In the second segment, Dr. Andrew Southerland talks with Dr. Steven Messe on his practice advisory update summary paper on patent foramen ovale and secondary stroke prevention. 

Disclosures can be found at Neurology.org.

CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.

May 18 2020

26mins

Play

Neurology Recall: Connectome

Podcast cover
Read more

In this replay of past episodes, we focus on interviews about the connectome. In the first interview, from Feb. 2019, Dr. Stacey Clardy talks with Dr. Michael Fox on mapping symptoms to brain networks. From Aug. 2019, Dr. Jeff Ratliff talks again with Dr. Michael Fox about network localization of cervical dystonia based on causal brain lesions. In the final interview, Dr. Nico Dosenbach talks about neural networks as they relate to deep brain stimulation, from a talk with Dr. Jeff Ratliff from April 2020. 

May 17 2020

41mins

Play

Treatment of Adult ADHD; Surrogates' Decisions after Acute Brain Injury

Podcast cover
Read more

In the first segment, Dr. Teshamae Monteith talks with Dr. Scott Hirsch about treatment of adult ADHD. In the second segment, Dr. David Lapides talks with Dr. David Hwang about his Neurology paper on factors impacting surrogate decision makers for acute brain injury patients. 

Disclosures can be found at Neurology.org.

CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.

May 11 2020

22mins

Play

SPECIAL REPORT: Dr. Renee Shellhaas on Demonstrating Courage in a Time of Uncertainty

Podcast cover
Read more

Dr. Jason Crowell talks with Dr. Renee Shellhaas on courage during COVID-19 and on demonstrating leadership as neurologists in these circumstances. Read Dr. Shellhaas' special editorial: https://n.neurology.org/content/early/2020/04/24/WNL.0000000000009496. For a clearing house of neurology related information on the coronavirus go to https://www.aan.com/tools-and-resources/covid-19-neurology-resource-center/ to stay up-to-date.

May 06 2020

15mins

Play

Epilepsy in the Elderly; Scrambling Pain in NMO

Podcast cover
Read more

In the first segment, Dr. Jeff Ratliff speaks with Dr. Scott Mintzer about epilepsy in the elderly. In the second segment, Dr. Jeff Ratliff talks with Dr. Maureen Mealy about her paper on the use of scrambler therapy for pain in neuromyelitis optica. 

Disclosures can be found at Neurology.org.

CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.

May 04 2020

25mins

Play

Neurology Recall: Myelopathies

Podcast cover
Read more

In this replay of past episodes of Delayed Recall, we have the April 2015 interviews focusing on systemic causes of myelopathies and, then, interviews from 2018 on acquired myelopathies. 

May 02 2020

1hr 1min

Play

SPECIAL REPORT: Dr. Thomas Oxley talks about stroke with COVID-19 in the young

Podcast cover
Read more

Dr. David Lapides talks with Dr. Thomas Oxley about stroke as a presenting feature of COVID-19 in the young. Read Dr. Oxley's special correspondence in NEJM: https://www.nejm.org/doi/full/10.1056/NEJMc2009787. For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date.

Apr 30 2020

9mins

Play

An update on delirium; Nocturnal blood pressure and cognition

Podcast cover
Read more

In the first segment, Dr. Greg Day speaks with Dr. Sharon Inouye about her NEJM article providing an update on delirium. The article is available online at: https://bit.ly/2UCh2Xo. In the second segment, Dr. Dan Ackerman talks with Dr. Adam Brickman about his Neurology paper on nocturnal blood pressure and cognition. 

Disclosures can be found at Neurology.org.

CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.

Apr 27 2020

20mins

Play

SPECIAL REPORT: Neil Busis & Brad Klein make teleneurology easy & fun--tips for billing and physical exams

Podcast cover
Read more

Dr. Jason Crowell talks with Dr. Neil Busis and Dr. Brad Klein about teleneurology, tips for billing, and exams during the COVID-19 pandemic. Read the special editorial by Drs. Busis and Klein: https://n.neurology.org/content/early/2020/04/24/WNL.0000000000009494. For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date.

Apr 24 2020

23mins

Play

SPECIAL REPORT: Dr. Ken Tyler dispels some of the misinformation about SARS-CoV2, & gives updates on antibody testing and ongoing clinical trials

Podcast cover
Read more

Dr. Stacey Clardy talks with Dr. Ken Tyler about misinformation about SARS-CoV2 & gives updates on antibody testing and ongoing clinical trials. For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date.

Apr 23 2020

34mins

Play

iTunes Ratings

113 Ratings
Average Ratings
86
16
4
2
5

Informative and relevant!

By Superstumbler - Mar 01 2020
Read more
Content is definitely a 5 but the audio quality could be better.

Best brain pod!

By nordiknut - Feb 25 2020
Read more
Highest praise!!! A MUST for Neurology residents!